首页/行业动态/论文详情

通过集成肽组学和分子动力学模拟从大麻种子蛋白中发现α-葡萄糖苷酶抑制肽

Discovery of α-glucosidase inhibitory peptides from hemp seed protein via integrated peptidomics and molecular dynamics simulation.

科研进展PubMed 论文(功能食品)机译

摘要机译

随着2型糖尿病患病率的不断上升,需要从天然食物来源开发安全有效的α-葡萄糖苷酶抑制剂。本研究采用肽组学、计算筛选和分子动力学(MD)模拟相结合的综合策略,从大麻籽蛋白水解物中发现新的α-葡萄糖苷酶抑制肽。

Nano-LC-MS/MS确定了4875个独特的肽,主要是短链序列(<1000 Da),通过硅胶过滤中的多参数从中选择了16个高置信度候选肽。分子对接优先考虑了7种肽,实验验证证实了4种有效抑制剂(YQF、YLY、FRF和FGPE)的IC值为4.45-6.49 mg/mL。动力学分析揭示了机械多样性:

200-ns MD模拟显示稳定的肽酶复合物,与催化残基的氢键和疏水相互作用驱动持续抑制。这些大麻衍生的肽代表潜在血糖管理应用的候选功能成分。

虽然体内验证仍有待执行,但集成的工作流程为基于机制的抗糖尿病食物肽筛选奠定了基础。

展开英文摘要原文

The escalating prevalence of type 2 diabetes mellitus necessitates the development of safe and effective α-glucosidase inhibitors from natural food sources. This study employed an integrated strategy combining peptidomics, computational screening, and molecular dynamics (MD) simulation to discover novel α-glucosidase inhibitory peptides from hemp seed protein hydrolysates. Nano-LC-MS/MS identified 4875 unique peptides, predominantly short-chain sequences (<1000 Da), from which 16 high-confidence candidates were selected through multi-parameter in silico filtering. Molecular docking prioritized seven peptides, with experimental validation confirming four potent inhibitors (YQF, YLY, FRF, and FGPE) exhibiting IC₅₀ values of 4.45-6.49 mg/mL. Kinetic analysis revealed mechanistic diversity: FRF displayed competitive inhibition, whereas YQF, YLY, and FGPE exhibited non-competitive inhibition. 200-ns MD simulations demonstrated stable peptide-enzyme complexes, with hydrogen bonding to catalytic residues and hydrophobic interactions driving sustained inhibition. These hemp-derived peptides represent candidate functional ingredients for potential glycemic management applications. While in vivo validation remains to be performed, the integrated workflow establishes a foundation for mechanism-based screening of antidiabetic food peptides.

相关物质

PubMed 原文 ↗DOI 入口 ↗

本页由系统自动抓取 PubMed 元数据生成;标题与摘要版权归原作者与期刊所有;机译内容仅供参考,请以英文原文为准;收录不代表本站观点,亦不作为用药或医疗建议。